IW
IMMX icon

Imprint Wealth’s Immix Biopharma IMMX Stock Holding History

Imprint Wealth’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$270K Sell
26,233
-5,015
-16% -$46.5K 1.1% 22
2026
Q1 		$285K Buy
31,248
+11,239
+56% +$82.5K 1.3% 22
2025
Q4 		$105K Sell
20,009
-47,414
-70% -$195K 0.49% 40
2025
Q3 		$141K Buy
+67,423
New +$162K 0.45% 47
2024
Q1 		$76.5K Sell
26,214
-8,269
-24% -$32K 0.02% 297
2023
Q4 		$143K Buy
34,483
+11,400
+49% +$51.6K 0.12% 153
2023
Q3 		$78.9K Buy
23,083
+803
+4% +$1.88K 0.07% 152
2023
Q2 		$42.3K Buy
+22,280
New +$46.7K 0.03% 170

Other funds holding IMMX

JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Imprint Wealth's IMMX Position: Q2 2026 in Review

Imprint Wealth reduced its Immix Biopharma (IMMX) stake by 16% in Q2 2026, selling an estimated $46.5K and leaving 26,233 shares worth $270K. The position accounts for 1.1% of the portfolio, ranked #22.

Imprint Wealth first reported a position in IMMX in Q2 2023 and has held it in 8 quarters since. The position peaked at $285K in Q1 2026. 109 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

  • Imprint Wealth held 26,233 shares of Immix Biopharma worth $270K as of Q2 2026.
  • Imprint Wealth sold 5,015 Immix Biopharma shares in Q2 2026, an estimated $46.5K.
  • Immix Biopharma made up 1.1% of Imprint Wealth's portfolio in Q2 2026, its #22 holding.
  • Imprint Wealth first reported a position in Immix Biopharma in Q2 2023 and has held it in 8 quarters since.
  • Imprint Wealth's Immix Biopharma position peaked at $285K in Q1 2026.
  • 109 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on Imprint Wealth's 13F filing for Q2 2026, filed 14 Aug 2026.